Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Magnificence of Do-It-Yourself Skincare: Regular Recipes and Tips - 25 Christmas movies to stream for less with this Paramount+ Black Friday deal
- 3Bahrain cracks down on dissent as war grinds on
- 4How Would You Like to Deal with Your Funds?
- 5Figure out How to Plan for Your Web-based Degree monetarily
- NASA wants to build a base on the Moon by the 2030s – how and why it plans to build up to a long-term lunar presence
- The Response to Independence from the rat race: Methodologies for Creating Financial momentum
- At least 30 killed in attack on Nigeria village
- Empathy and reasoning aren’t rivals – new research shows they work together to drive people to help more
- A NASA spacecraft orbiting Mars may be dead
- Before trips to Mars, we need better protection from cosmic rays
- Figure out How to Amplify the Resale Worth of Your Kona SUV
- 10 Distinct Kinds of Chinese Neighborhood Specialty Hot Pot
- Kate Hudson, 46, says she doesn't need long workouts to feel good
